Peptide PilotPeptide Pilot

mg ↔ units

MOTS-c mg to units converter

Set your MOTS-c vial concentration once, then flip in either direction between milligrams and U-100 syringe units.

Download Peptide PilotiPhone · Free to download

mg

5.000

units

100.0

mL

1.000

Concentration: 5.00 mg/mL (assumes a U-100 insulin syringe).

MOTS-c is a peptide encoded inside the mitochondria that people inject for metabolic effects — energy, insulin sensitivity, and exercise capacity. It signals to muscle and fat tissue to use glucose and fat more efficiently, essentially mimicking some effects of exercise at the cellular level. Animal studies show clear improvements in insulin sensitivity and endurance; human data is early. This page covers reconstitution math and a typical 2–3-times-per-week logging cadence.

How the MOTS-c mg ↔ units converter works

This converter is a two-way bridge between dose mass (mg or mcg) and the unit count you actually draw on an insulin syringe. Once you set the MOTS-c concentration of your current vial, you can type any mg value and read the units back, or type any unit count and read the mg back. It is the same math as the dose calculator, but bidirectional, which matters when you are checking a dose someone else recorded in units against a protocol written in mg.

The formula in both directions: mg = mL × concentration mg/mL, and units = mL × 100 on a U-100 syringe. With a 5 mg/mL MOTS-c solution, 5 mg comes out to 100 units, and 100 units comes out to 5 mg. The converter handles the unit flip automatically so you never multiply or divide in your head while holding a syringe.

Concentration is the input that changes the answer most. A 10 mg vial diluted with 1 mL is twice as concentrated as the same vial diluted with 2 mL, which means the same dose draws half as many units. That is the single biggest source of converter confusion: a remembered unit count from an old vial does not transfer to a new vial reconstituted with different water volume.

Use the converter whenever a protocol or research note is written in one unit and your syringe is labeled in the other. It is also useful for sanity-checking that a planned titration step lands at a unit count you can read accurately on the syringe — under five units gets hard to read, over fifty starts crowding into the back third of a 1 mL syringe.

Why this matters for MOTS-c

MOTS-c is distinguished from other peptides in this catalog by its unique biological origin: it is a mitochondrial-derived peptide, encoded by a small open reading frame within the mitochondrial genome rather than by nuclear DNA. This fundamental difference places it in a distinct class of signaling molecules. Discovered in 2015 by a research group led by Pinchas Cohen and Changhan Lee at the University of Southern California, MOTS-c emerged from investigations into the signaling roles of molecules produced by mitochondria. As an endogenous peptide, its existence highlights a novel layer of communication between the cell's powerhouses and the rest of the cellular machinery.

The primary interest in tracking MOTS-c protocols stems from its researched role in metabolic homeostasis. Scientific literature has framed its function around the regulation of cellular energy, particularly through pathways sensitive to nutrient and energy status. Personal tracking logs often focus on documenting its administration relative to metabolic state, diet, and exercise. Because it originates within the mitochondrion, it is often studied in contexts involving cellular stress, adaptation, and energy expenditure, providing a unique variable for individuals monitoring their metabolic parameters.

The peptide MOTS-c was first described by researchers Changhan Lee, Pinchas Cohen, and their colleagues at the University of Southern California. Its discovery was detailed in a 2015 paper published in *Cell Metabolism*. A key distinction of MOTS-c is its origin; it is encoded by a small open reading frame within the 12S rRNA region of mitochondrial DNA. This makes it the only known peptide with a mitochondrial genome origin that is studied for its systemic signaling functions.

MOTS-c mechanism in plain English

Research into MOTS-c's mechanism has consistently highlighted its interaction with the AMP-activated protein kinase (AMPK) pathway. AMPK functions as a master regulator of cellular energy balance, activated during states of low energy (high AMP:ATP ratio) to switch on catabolic processes and switch off anabolic, energy-consuming processes. Studies in various cell and animal models have observed that MOTS-c can influence AMPK activation. This interaction provides a molecular basis for the peptide's observed effects on glucose utilization and fatty acid oxidation in experimental settings. Its action on this critical energy-sensing pathway is central to its scientific characterization and the rationale for its study in metabolic contexts.

Scientific literature documents the interaction between MOTS-c and the AMP-activated protein kinase (AMPK) pathway. As a key cellular energy sensor, the AMPK pathway is a subject of study for its role in responding to metabolic stressors like exercise or caloric restriction. Research protocols are often designed to observe how MOTS-c may influence this pathway's activity. For this reason, MOTS-c is sometimes grouped with exercise mimetics in research contexts, and individuals can use tracking tools to document relevant observations.

Tracking MOTS-c unit counts

The every-other-day or three-times-per-week cadence associated with MOTS-c presents a distinct tracking challenge compared to simpler schedules. This irregular pattern is uniquely susceptible to unintentional drift, where the intended frequency is not maintained over time. To counteract this, a meticulous log is essential for documenting the exact date and time of each administration. Such a detailed record is the only reliable method for retrospectively auditing the actual dosing schedule and observing its consistency, which is a primary goal of personal protocol tracking.

For a detailed personal log, one can track more than just the administration schedule. Given the research focus on energy homeostasis, individuals could document exercise-related metrics like endurance performance or perceived exertion levels. Other relevant data points to monitor might include body composition figures or subjective scores for daily energy. Documenting these variables alongside a MOTS-c schedule allows for a more comprehensive personal audit, revealing patterns that may be of interest for future review.

Common MOTS-c conversion mistakes

  • Failing to maintain a strict calendar-based log, leading to the every-other-day schedule drifting into an inconsistent and untrackable pattern.
  • Calculating a unit dose based on a generic concentration instead of the specific concentration derived from their vial size and chosen diluent volume.
  • Reconstituting a 10 mg vial with 2 mL of water and being unprepared for the large 1 mL (100 unit) injection volume required for a 5 mg dose.
  • Confusing MOTS-c's classification as a mitochondrial-derived peptide with unsupported claims about its direct effects on mitochondrial populations.
  • Assuming the administration timing relative to meals or exercise is irrelevant without systematically tracking it as a variable in a personal log.
  • Confusing its studied mechanism with other metabolic peptides, overlooking that its mitochondrial origin represents a distinct signaling pathway.
  • Committing calculation errors when converting between milligrams and micrograms, a frequent issue due to its higher milligram-level doses.
  • Failing to consistently document the administration cadence (e.g., every other day), a key variable studied for its effect on signaling pathways.

Frequently asked questions about MOTS-c mg ↔ units

What specifically makes MOTS-c different from other peptides tracked on this site?
MOTS-c is unique because it is a mitochondrial-derived peptide (MDP). This means its genetic code originates from DNA within the mitochondria, not the cell's nucleus. All other peptides in this catalog are either encoded by the nuclear genome or are fully synthetic analogs, making MOTS-c's biological origin fundamentally distinct.
How do I use the calculator to find how many units to draw for a 5 mg dose?
First, you must establish the concentration. If you reconstitute a 10 mg vial with 2 mL of bacteriostatic water, the concentration is 5 mg per mL. Since a U-100 insulin syringe holds 1 mL total, a 5 mg dose requires a full 1 mL of this solution, which equals 100 units on the syringe.
Why is it so important to log every MOTS-c administration date?
The common three-times-per-week or every-other-day schedule lacks the simple repetition of daily or weekly protocols. This irregularity makes it very easy for the schedule to drift over time. A precise log with dates ensures you have an accurate record of the actual frequency, which is necessary to review the consistency of your self-directed protocol.
What is the significance of the AMPK pathway in relation to MOTS-c?
The AMP-activated protein kinase (AMPK) pathway is a primary cellular energy sensor. Much of the scientific research on MOTS-c has studied its ability to influence this pathway. This interaction is the proposed mechanism through which MOTS-c exerts effects on metabolism, and it provides the scientific framework for its investigation in studies of metabolic regulation.
Can I reconstitute the 10 mg vial with a different volume of water, like 1 mL?
Yes, the diluent volume can be adjusted, but it changes the dose calculation. Using 1 mL of water in a 10 mg vial would create a 10 mg/mL solution. A 5 mg dose would then require only 0.5 mL (50 units), which may be a more comfortable injection volume for some individuals. It is critical to use the calculator to convert your desired dose based on your actual concentration.
Was MOTS-c invented in a lab or discovered in nature?
MOTS-c was discovered. A research team at the University of Southern California identified it in 2015 as a naturally occurring peptide produced within mitochondria. It is therefore classified as an endogenous signaling molecule, not a synthetic compound that was invented or designed in a laboratory.
What is the research origin of MOTS-c?
MOTS-c was first described in a 2015 *Cell Metabolism* paper by researchers at the University of Southern California. Its unique characteristic is its origin from the mitochondrial genome, specifically from a small open reading frame in the 12S rRNA gene. This classifies it as a mitochondrial-derived peptide (MDP), distinguishing it from peptides encoded by nuclear DNA.
Why do some study protocols for MOTS-c specify an every-other-day cadence?
The every-other-day or three-times-per-week cadence observed in certain research is planned in relation to the peptide's studied properties. MOTS-c is documented to have a relatively short half-life. An intermittent schedule allows researchers to observe the effects of pulsing or cyclically activating cellular pathways, such as the AMPK pathway, rather than inducing a state of constant saturation that might occur with daily administration.
What does the 'MOTS-c' acronym represent?
The acronym MOTS-c stands for 'Mitochondrial Open reading frame of the Twelve S rRNA-c'. This name is a direct description of its genetic location. It is derived from a small open reading frame (ORF) on the 12S ribosomal RNA (rRNA) gene, which is located in the mitochondrial DNA.

Related on Peptide Pilot

Save your MOTS-c vial in the app

Download on the App Store
Get the App